{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:43:34Z","timestamp":1792806214158,"version":"4.5.0"},"reference-count":40,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>\n                      Superficial temporal artery\u2013middle cerebral artery (STA-MCA) anastomosis is the standard surgical management for moyamoya disease (MMD), whereas cerebral hyperperfusion (CHP) is one of the potential complications of this procedure that can result in delayed intracerebral hemorrhage and\/or neurological deterioration. Recent advances in perioperative management in the early postoperative period have significantly reduced the risk of CHP syndrome, but delayed intracerebral hemorrhage and prolonged\/delayed CHP are still major clinical issues. The clinical implication of\n                      <jats:italic>RNF213<\/jats:italic>\n                      gene polymorphism c.14576G&gt;A (rs112735431), a susceptibility variant for MMD, includes early disease onset and a more severe form of MMD, but its significance in perioperative pathology is unknown. Thus, the authors investigated the role of\n                      <jats:italic>RNF213<\/jats:italic>\n                      polymorphism in perioperative hemodynamics after STA-MCA anastomosis for MMD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>\n                      Among 96 consecutive adult patients with MMD comprising 105 hemispheres who underwent serial quantitative cerebral blood flow (CBF) analysis by\n                      <jats:italic>N<\/jats:italic>\n                      -isopropyl-\n                      <jats:italic>p<\/jats:italic>\n                      -[\n                      <jats:sup>123<\/jats:sup>\n                      I]iodoamphetamine SPECT after STA-MCA anastomosis, 66 patients consented to genetic analysis of\n                      <jats:italic>RNF213<\/jats:italic>\n                      . Patients were routinely maintained under strict blood pressure control during and after surgery. The local CBF values were quantified at the vascular territory supplied by the bypass on postoperative days (PODs) 1 and 7. The authors defined the radiological CHP phenomenon as a local CBF increase of more than 150% compared with the preoperative values, and then they investigated the correlation between\n                      <jats:italic>RNF213<\/jats:italic>\n                      polymorphism and the development of CHP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      CHP at POD 1 was observed in 23 hemispheres (23\/73 hemispheres [31.5%]), and its incidence was not statistically different between groups (15\/41 [36.6%] in\n                      <jats:italic>RNF213<\/jats:italic>\n                      -mutant group vs 8\/32 [25.0%] in\n                      <jats:italic>RNF213<\/jats:italic>\n                      \u2013wild type (WT) group; p = 0.321). CHP on POD 7, which is a relatively late period of the CHP phenomenon in MMD, was evident in 9 patients (9\/73 hemispheres [12.3%]) after STA-MCA anastomosis. This prolonged\/delayed CHP was exclusively observed in the\n                      <jats:italic>RNF213<\/jats:italic>\n                      -mutant group (9\/41 [22.0%] in the\n                      <jats:italic>RNF213<\/jats:italic>\n                      -mutant group vs 0\/32 [0.0%] in the\n                      <jats:italic>RNF213<\/jats:italic>\n                      -WT group; p = 0.004). Multivariate analysis revealed that\n                      <jats:italic>RNF213<\/jats:italic>\n                      polymorphism was significantly associated with CBF increase on POD 7 (OR 5.47, 95% CI 1.06\u201328.35; p = 0.043).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>\n                      Prolonged\/delayed CHP after revascularization surgery was exclusively found in the\n                      <jats:italic>RNF213<\/jats:italic>\n                      -mutant group. Although the exact mechanism underlying the contribution of\n                      <jats:italic>RNF213<\/jats:italic>\n                      polymorphism to the prolonged\/delayed CBF increase in patients with MMD is unclear, the current study suggests that genetic analysis of\n                      <jats:italic>RNF213<\/jats:italic>\n                      is useful for predicting the perioperative pathology of patients with MMD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2020.6.jns201037","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T03:50:52Z","timestamp":1603425052000},"page":"417-424","source":"Crossref","is-referenced-by-count":26,"title":["Prolonged\/delayed cerebral hyperperfusion in adult patients with moyamoya disease with RNF213 gene polymorphism c.14576G&gt;A (rs112735431) after superficial temporal artery\u2013middle cerebral artery anastomosis"],"prefix":"10.3171","volume":"135","author":[{"given":"Ryosuke","family":"Tashiro","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Kohnan Hospital, Sendai;"},{"name":"Department of Neurosurgery, Graduate School of Medicine, Tohoku University, Sendai; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Fujimura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kohnan Hospital, Sendai;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Katsuki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kohnan Hospital, Sendai;"},{"name":"Department of Neurosurgery, Graduate School of Medicine, Tohoku University, Sendai; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Nishizawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kohnan Hospital, Sendai;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutake","family":"Tomata","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Health Informatics and Public Health, Tohoku University School of Public Health, Graduate School of Medicine, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniyasu","family":"Niizuma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine, Tohoku University, Sendai; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"Tominaga","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medicine, Tohoku University, Sendai; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"5","key":"b1","series-title":"Neurol Med Chir (Tokyo)","first-page":"327","article-title":"Lessons learned from moyamoya disease: outcome of direct\/indirect revascularization surgery for 150 affected hemispheres","volume":"52","author":"Fujimura\n \nM","year":"2012","unstructured":"Fujimura\n \nM\n\n, \n\nTominaga\n \nT\n\n\n. \nLessons learned from moyamoya disease: outcome of direct\/indirect revascularization surgery for 150 affected hemispheres\n. \nNeurol Med Chir (Tokyo)\n. \n2012\n;\n52\n(\n5\n):\n327\n\u2013\n332\n."},{"issue":"10","key":"b2","series-title":"Stroke","first-page":"3025","article-title":"Long-term outcomes after combined revascularization surgery in adult moyamoya disease","volume":"45","author":"Cho\n \nWS","year":"2014","unstructured":"Cho\n \nWS\n\n, \n\nKim\n \nJE\n\n, \n\nKim\n \nCH\n\n, \n\n\n \nLong-term outcomes after combined revascularization surgery in adult moyamoya disease\n. \nStroke\n. \n2014\n;\n45\n(\n10\n):\n3025\n\u2013\n3031\n."},{"issue":"5","key":"b3","series-title":"Stroke","first-page":"1415","article-title":"Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial","volume":"45","author":"Miyamoto\n \nS","year":"2014","unstructured":"Miyamoto\n \nS\n\n, \n\nYoshimoto\n \nT\n\n, \n\nHashimoto\n \nN\n\n, \n\n\n \nEffects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial\n. \nStroke\n. \n2014\n;\n45\n(\n5\n):\n1415\n\u2013\n1421\n."},{"issue":"1","key":"b4","series-title":"Tohoku J Exp Med","first-page":"45","article-title":"Current status of revascularization surgery for Moyamoya disease: special consideration for its \u2018internal carotid-external carotid (IC-EC) conversion\u2019 as the physiological reorganization system","volume":"236","author":"Fujimura\n \nM","year":"2015","unstructured":"Fujimura\n \nM\n\n, \n\nTominaga\n \nT\n\n\n. \nCurrent status of revascularization surgery for Moyamoya disease: special consideration for its \u2018internal carotid-external carotid (IC-EC) conversion\u2019 as the physiological reorganization system\n. \nTohoku J Exp Med\n. \n2015\n;\n236\n(\n1\n):\n45\n\u2013\n53\n."},{"issue":"1","key":"b5","series-title":"Stroke","first-page":"37","article-title":"Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya Trial","volume":"47","author":"Takahashi\n \nJC","year":"2016","unstructured":"Takahashi\n \nJC\n\n, \n\nFunaki\n \nT\n\n, \n\nHoukin\n \nK\n\n, \n\n\n \nSignificance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya Trial\n. \nStroke\n. \n2016\n;\n47\n(\n1\n):\n37\n\u2013\n43\n."},{"issue":"3","key":"b6","series-title":"J Neurosurg","first-page":"793","article-title":"Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults","volume":"128","author":"Jeon\n \nJP","year":"2018","unstructured":"Jeon\n \nJP\n\n, \n\nKim\n \nJE\n\n, \n\nCho\n \nWS\n\n, \n\n\n \nMeta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults\n. \nJ Neurosurg\n. \n2018\n;\n128\n(\n3\n):\n793\n\u2013\n799\n."},{"issue":"5","key":"b7","series-title":"Neurol Med Chir (Tokyo)","first-page":"245","article-title":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","author":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis\n\n\n. \nGuidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)\n. \nNeurol Med Chir (Tokyo)\n. \n2012\n;\n52\n(\n5\n):\n245\n\u2013\n266\n."},{"issue":"1","key":"b8","series-title":"Surg Cereb Stroke","first-page":"136","article-title":"Recommendations for the management of Moyamoya Disease: a statement from Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) [2nd Edition]. Article in Japanese","volume":"46","author":"Tominaga\n \nT","year":"2018","unstructured":"Tominaga\n \nT\n\n, \n\nSuzuki\n \nN\n\n, \n\nMiyamoto\n \nS\n\n, \n\n\n \nRecommendations for the management of Moyamoya Disease: a statement from Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) [2nd Edition]. Article in Japanese\n. \nSurg Cereb Stroke\n. \n2018\n;\n46\n(\n1\n):\n136\n\u2013\n140\n."},{"issue":"3","key":"b9","series-title":"Surg Neurol","first-page":"273","article-title":"Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease","volume":"67","author":"Fujimura\n \nM","year":"2007","unstructured":"Fujimura\n \nM\n\n, \n\nKaneta\n \nT\n\n, \n\nMugikura\n \nS\n\n, \n\n\n \nTemporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease\n. \nSurg Neurol\n. \n2007\n;\n67\n(\n3\n):\n273\n\u2013\n282\n."},{"issue":"6","key":"b10","series-title":"Cerebrovasc Dis","first-page":"580","article-title":"Transient hyperperfusion after superficial temporal artery\/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration","volume":"25","author":"Kim\n \nJE","year":"2008","unstructured":"Kim\n \nJE\n\n, \n\nOh\n \nCW\n\n, \n\nKwon\n \nOK\n\n, \n\n\n \nTransient hyperperfusion after superficial temporal artery\/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration\n. \nCerebrovasc Dis\n. \n2008\n;\n25\n(\n6\n):\n580\n\u2013\n586\n."},{"issue":"4","key":"b11","series-title":"Surg Neurol","first-page":"442","article-title":"Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease","volume":"71","author":"Fujimura\n \nM","year":"2009","unstructured":"Fujimura\n \nM\n\n, \n\nMugikura\n \nS\n\n, \n\nKaneta\n \nT\n\n, \n\n\n \nIncidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease\n. \nSurg Neurol\n. \n2009\n;\n71\n(\n4\n):\n442\n\u2013\n447\n."},{"issue":"2","key":"b12","series-title":"Neurosurg Rev","first-page":"245","article-title":"Cerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalo-myo-synangiosis in moyamoya disease","volume":"32","author":"Fujimura\n \nM","year":"2009","unstructured":"Fujimura\n \nM\n\n, \n\nKaneta\n \nT\n\n, \n\nShimizu\n \nH\n\n, \n\nTominaga\n \nT\n\n\n. \nCerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalo-myo-synangiosis in moyamoya disease\n. \nNeurosurg Rev\n. \n2009\n;\n32\n(\n2\n):\n245\n\u2013\n249\n."},{"issue":"2","key":"b13","series-title":"Surg Neurol","first-page":"223","article-title":"Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability","volume":"71","author":"Fujimura\n \nM","year":"2009","unstructured":"Fujimura\n \nM\n\n, \n\nShimizu\n \nH\n\n, \n\nMugikura\n \nS\n\n, \n\nTominaga\n \nT\n\n\n. \nDelayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability\n. \nSurg Neurol\n. \n2009\n;\n71\n(\n2\n):\n223\n\u2013\n227\n."},{"issue":"4","key":"b14","series-title":"Neurosurgery","first-page":"957","article-title":"Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography","volume":"68","author":"Fujimura\n \nM","year":"2011","unstructured":"Fujimura\n \nM\n\n, \n\nShimizu\n \nH\n\n, \n\nInoue\n \nT\n\n, \n\n\n \nSignificance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography\n. \nNeurosurgery\n. \n2011\n;\n68\n(\n4\n):\n957\n\u2013\n965\n."},{"issue":"10","key":"b15","series-title":"Stroke","first-page":"2610","article-title":"Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT\/positron emission tomography study","volume":"43","author":"Uchino\n \nH","year":"2012","unstructured":"Uchino\n \nH\n\n, \n\nKuroda\n \nS\n\n, \n\nHirata\n \nK\n\n, \n\n\n \nPredictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT\/positron emission tomography study\n. \nStroke\n. \n2012\n;\n43\n(\n10\n):\n2610\n\u2013\n2616\n."},{"issue":"5","key":"b16","series-title":"Cerebrovasc Dis","first-page":"436","article-title":"Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease","volume":"33","author":"Fujimura\n \nM","year":"2012","unstructured":"Fujimura\n \nM\n\n, \n\nInoue\n \nT\n\n, \n\nShimizu\n \nH\n\n, \n\n\n \nEfficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease\n. \nCerebrovasc Dis\n. \n2012\n;\n33\n(\n5\n):\n436\n\u2013\n445\n."},{"issue":"2","key":"b17","series-title":"Neurosurgery","first-page":"163","article-title":"Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease","volume":"74","author":"Fujimura\n \nM","year":"2014","unstructured":"Fujimura\n \nM\n\n, \n\nNiizuma\n \nK\n\n, \n\nInoue\n \nT\n\n, \n\n\n \nMinocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease\n. \nNeurosurgery\n. \n2014\n;\n74\n(\n2\n):\n163\n\u2013\n170\n."},{"issue":"10","key":"b18","series-title":"Neurol Med Chir (Tokyo)","first-page":"775","article-title":"Significance of cerebral blood flow analysis in the acute stage after revascularization surgery for moyamoya disease","volume":"55","author":"Fujimura\n \nM","year":"2015","unstructured":"Fujimura\n \nM\n\n, \n\nTominaga\n \nT\n\n\n. \nSignificance of cerebral blood flow analysis in the acute stage after revascularization surgery for moyamoya disease\n. \nNeurol Med Chir (Tokyo)\n. \n2015\n;\n55\n(\n10\n):\n775\n\u2013\n781\n."},{"key":"b19","series-title":"Surg Neurol Int","first-page":"106","article-title":"Prolonged and regionally progressive symptomatic cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease","volume":"3","author":"Takemoto\n \nY","year":"2012","unstructured":"Takemoto\n \nY\n\n, \n\nMorioka\n \nM\n\n, \n\nNakagawa\n \nT\n\n, \n\n\n \nProlonged and regionally progressive symptomatic cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease\n. \nSurg Neurol Int\n. \n2012\n;\n3\n:\n106\n."},{"key":"b20","series-title":"World Neurosurg","first-page":"e774","article-title":"Intracranial hemorrhage after superficial temporal artery\u2013middle cerebral artery direct anastomosis for adults with moyamoya disease","volume":"119","author":"Park\n \nW","year":"2018","unstructured":"Park\n \nW\n\n, \n\nPark\n \nES\n\n, \n\nLee\n \nS\n\n, \n\n\n \nIntracranial hemorrhage after superficial temporal artery\u2013middle cerebral artery direct anastomosis for adults with moyamoya disease\n. \nWorld Neurosurg\n. \n2018\n;\n119\n:\ne774\n\u2013\ne782\n."},{"issue":"1","key":"b21","series-title":"J Hum Genet","first-page":"34","article-title":"A genome-wide association study identifies RNF213 as the first Moyamoya disease gene","volume":"56","author":"Kamada\n \nF","year":"2011","unstructured":"Kamada\n \nF\n\n, \n\nAoki\n \nY\n\n, \n\nNarisawa\n \nA\n\n, \n\n\n \nA genome-wide association study identifies RNF213 as the first Moyamoya disease gene\n. \nJ Hum Genet\n. \n2011\n;\n56\n(\n1\n):\n34\n\u2013\n40\n."},{"issue":"7","key":"b22","series-title":"PLoS One","article-title":"Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development","volume":"6","author":"Liu\n \nW","year":"2011","unstructured":"Liu\n \nW\n\n, \n\nMorito\n \nD\n\n, \n\nTakashima\n \nS\n\n, \n\n\n \nIdentification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development\n. \nPLoS One\n. \n2011\n;\n6\n(\n7\n):\ne22542\n."},{"issue":"11","key":"b23","series-title":"Neurology","first-page":"803","article-title":"Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease","volume":"78","author":"Miyatake\n \nS","year":"2012","unstructured":"Miyatake\n \nS\n\n, \n\nMiyake\n \nN\n\n, \n\nTouho\n \nH\n\n, \n\n\n \nHomozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease\n. \nNeurology\n. \n2012\n;\n78\n(\n11\n):\n803\n\u2013\n810\n."},{"issue":"3-4","key":"b24","series-title":"Cerebrovasc Dis","first-page":"105","article-title":"Genotype-phenotype correlation in long-term cohort of Japanese patients with moyamoya disease","volume":"47","author":"Nomura\n \nS","year":"2019","unstructured":"Nomura\n \nS\n\n, \n\nYamaguchi\n \nK\n\n, \n\nAkagawa\n \nH\n\n, \n\n\n \nGenotype-phenotype correlation in long-term cohort of Japanese patients with moyamoya disease\n. \nCerebrovasc Dis\n. \n2019\n;\n47\n(\n3-4\n):\n105\n\u2013\n111\n."},{"key":"b25","series-title":"Front Neurol","first-page":"662","article-title":"Association between p.R4810K variant and long-term clinical outcome in patients with moyamoya disease","volume":"10","author":"Ge\n \nP","year":"2019","unstructured":"Ge\n \nP\n\n, \n\nYe\n \nX\n\n, \n\nLiu\n \nX\n\n, \n\n\n \nAssociation between p.R4810K variant and long-term clinical outcome in patients with moyamoya disease\n. \nFront Neurol\n. \n2019\n;\n10\n:\n662\n."},{"issue":"13","key":"b26","series-title":"J Child Neurol","first-page":"793","article-title":"Clinical features and surgical outcomes of patients with moyamoya disease and the homozygous RNF213 p.R4810K variant","volume":"34","author":"Zhang\n \nQ","year":"2019","unstructured":"Zhang\n \nQ\n\n, \n\nGe\n \nP\n\n, \n\nMa\n \nY\n\n, \n\n\n \nClinical features and surgical outcomes of patients with moyamoya disease and the homozygous RNF213 p.R4810K variant\n. \nJ Child Neurol\n. \n2019\n;\n34\n(\n13\n):\n793\n\u2013\n800\n."},{"issue":"2","key":"b27","series-title":"Neurol Res","first-page":"131","article-title":"Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease","volume":"37","author":"Fujimura\n \nM","year":"2015","unstructured":"Fujimura\n \nM\n\n, \n\nNiizuma\n \nK\n\n, \n\nEndo\n \nH\n\n, \n\n\n \nQuantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease\n. \nNeurol Res\n. \n2015\n;\n37\n(\n2\n):\n131\n\u2013\n138\n."},{"issue":"3-4","key":"b28","series-title":"Cerebrovasc Dis","first-page":"178","article-title":"Incidence and risk factors of the watershed shift phenomenon after superficial temporal artery-middle cerebral artery anastomosis for adult moyamoya disease","volume":"47","author":"Tashiro\n \nR","year":"2019","unstructured":"Tashiro\n \nR\n\n, \n\nFujimura\n \nM\n\n, \n\nKameyama\n \nM\n\n, \n\n\n \nIncidence and risk factors of the watershed shift phenomenon after superficial temporal artery-middle cerebral artery anastomosis for adult moyamoya disease\n. \nCerebrovasc Dis\n. \n2019\n;\n47\n(\n3-4\n):\n178\n\u2013\n187\n."},{"issue":"3-6","key":"b29","series-title":"Cerebrovasc Dis","first-page":"217","article-title":"Significance of quantitative cerebral blood flow measurement in the acute stage after revascularization surgery for adult moyamoya diease: implication for the pathological threshold of local cerebral hyperperfuion","volume":"48","author":"Kameyama\n \nM","year":"2019","unstructured":"Kameyama\n \nM\n\n, \n\nFujimura\n \nM\n\n, \n\nTashiro\n \nR\n\n, \n\n\n \nSignificance of quantitative cerebral blood flow measurement in the acute stage after revascularization surgery for adult moyamoya diease: implication for the pathological threshold of local cerebral hyperperfuion\n. \nCerebrovasc Dis\n. \n2019\n;\n48\n(\n3-6\n):\n217\n\u2013\n225\n."},{"key":"b30","series-title":"Neurosurg Rev. Published online February","article-title":"Crossed cerebellar diaschisis as an indicator of severe cerebral hyperperfusion after direct bypass for moyamoya disease","volume":"19","author":"Uchino\n \nH","year":"2020","unstructured":"Uchino\n \nH\n\n, \n\nKazumata\n \nK\n\n, \n\nIto\n \nM\n\n, \n\n\n \nCrossed cerebellar diaschisis as an indicator of severe cerebral hyperperfusion after direct bypass for moyamoya disease\n. \n\nNeurosurg Rev. Published online February\n \n19\n, \n2020\n. \ndoi:10.1007\/s10143-020-01265-8"},{"issue":"9","key":"b31","series-title":"Neurol Res","first-page":"811","article-title":"Genetic analysis of ring finger protein 213 (RNF213) c.14576G>A polymorphism in patients with vertebral artery dissection: a comparative study with moyamoya disease","volume":"41","author":"Tashiro\n \nR","year":"2019","unstructured":"Tashiro\n \nR\n\n, \n\nFujimura\n \nM\n\n, \n\nSakata\n \nH\n\n, \n\n\n \nGenetic analysis of ring finger protein 213 (RNF213) c.14576G>A polymorphism in patients with vertebral artery dissection: a comparative study with moyamoya disease\n. \nNeurol Res\n. \n2019\n;\n41\n(\n9\n):\n811\n\u2013\n816\n."},{"issue":"8","key":"b32","series-title":"PLoS One","article-title":"Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: a case-control study","volume":"14","author":"Tashiro\n \nR","year":"2019","unstructured":"Tashiro\n \nR\n\n, \n\nNiizuma\n \nK\n\n, \n\nKhor\n \nSS\n\n, \n\n\n \nIdentification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: a case-control study\n. \nPLoS One\n. \n2019\n;\n14\n(\n8\n):\ne0220858\n."},{"issue":"1","key":"b33","series-title":"Neurol Med Chir (Tokyo)","first-page":"1","article-title":"Histological features of middle cerebral arteries from patients treated for Moyamoya disease","volume":"47","author":"Takagi\n \nY","year":"2007","unstructured":"Takagi\n \nY\n\n, \n\nKikuta\n \nK\n\n, \n\nNozaki\n \nK\n\n, \n\nHashimoto\n \nN\n\n\n. \nHistological features of middle cerebral arteries from patients treated for Moyamoya disease\n. \nNeurol Med Chir (Tokyo)\n. \n2007\n;\n47\n(\n1\n):\n1\n\u2013\n4\n."},{"issue":"5","key":"b34","series-title":"Surg Neurol","first-page":"476","article-title":"Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease","volume":"72","author":"Fujimura\n \nM","year":"2009","unstructured":"Fujimura\n \nM\n\n, \n\nWatanabe\n \nM\n\n, \n\nNarisawa\n \nA\n\n, \n\n\n \nIncreased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease\n. \nSurg Neurol\n. \n2009\n;\n72\n(\n5\n):\n476\n\u2013\n480\n."},{"issue":"2","key":"b35","series-title":"Acta Neurochir (Wien)","first-page":"371","article-title":"In vivo demonstration of blood-brain barrier impairment in Moyamoya disease","volume":"161","author":"Narducci\n \nA","year":"2019","unstructured":"Narducci\n \nA\n\n, \n\nYasuyuki\n \nK\n\n, \n\nOnken\n \nJ\n\n, \n\n\n \nIn vivo demonstration of blood-brain barrier impairment in Moyamoya disease\n. \nActa Neurochir (Wien)\n. \n2019\n;\n161\n(\n2\n):\n371\n\u2013\n378\n."},{"key":"b36","series-title":"Brain Res","first-page":"310","article-title":"Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease","volume":"1594","author":"Ito\n \nA","year":"2015","unstructured":"Ito\n \nA\n\n, \n\nFujimura\n \nM\n\n, \n\nNiizuma\n \nK\n\n, \n\n\n \nEnhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease\n. \nBrain Res\n. \n2015\n;\n1594\n:\n310\n\u2013\n320\n."},{"issue":"2","key":"b37","series-title":"Childs Nerv Syst","first-page":"309","article-title":"Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism","volume":"35","author":"Kim\n \nWH","year":"2019","unstructured":"Kim\n \nWH\n\n, \n\nKim\n \nSD\n\n, \n\nNam\n \nMH\n\n, \n\n\n \nPosterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism\n. \nChilds Nerv Syst\n. \n2019\n;\n35\n(\n2\n):\n309\n\u2013\n314\n."},{"issue":"3","key":"b38","series-title":"Neurosurg Rev.","first-page":"507","article-title":"Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the \u2018watershed shift","volume":"40","author":"Tu\n \nXK","year":"2017","unstructured":"Tu\n \nXK\n\n, \n\nFujimura\n \nM\n\n, \n\nRashad\n \nS\n\n, \n\n\n \nUneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the \u2018watershed shift\n.\u2019 \nNeurosurg Rev.\n \n2017\n;\n40\n(\n3\n):\n507\n\u2013\n512\n."},{"issue":"1","key":"b39","series-title":"J Neurosurg Pediatr","first-page":"73","article-title":"Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion","volume":"6","author":"Hayashi\n \nT","year":"2010","unstructured":"Hayashi\n \nT\n\n, \n\nShirane\n \nR\n\n, \n\nFujimura\n \nM\n\n, \n\nTominaga\n \nT\n\n\n. \nPostoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion\n. \nJ Neurosurg Pediatr\n. \n2010\n;\n6\n(\n1\n):\n73\n\u2013\n81\n."},{"key":"b40","series-title":"World Neurosurg","first-page":"e750","article-title":"Predicting the occurrence of hemorrhagic cerebral hyperperfusion syndrome using regional cerebral blood flow after direct bypass surgery in patients with moyamoya disease","volume":"119","author":"Ishikawa\n \nT","year":"2018","unstructured":"Ishikawa\n \nT\n\n, \n\nYamaguchi\n \nK\n\n, \n\nKawashima\n \nA\n\n, \n\n\n \nPredicting the occurrence of hemorrhagic cerebral hyperperfusion syndrome using regional cerebral blood flow after direct bypass surgery in patients with moyamoya disease\n. \nWorld Neurosurg\n. \n2018\n;\n119\n:\ne750\n\u2013\ne756\n."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/135\/2\/article-p417.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/135\/2\/article-p417.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/135\/2\/article-p417.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:31:47Z","timestamp":1792805507000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/135\/2\/article-p417.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":40,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2020.6.jns201037","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}